Pipeline Overview

Compound Code Therapeutic Area Discovery Preclinical Phase 1 Phase 2 Phase 3 Intellectual Property Status
CSM004 CNS
Discovery Preclinical Phase 1 Phase 2 Phase 3
44% Complete
Granted
CSM045 Anti-Diabetes
Discovery Preclinical Phase 1 Phase 2 Phase 3
44% Complete
Complete Filed
CSM050 Anti-Parkinson's
Discovery Preclinical Phase 1 Phase 2 Phase 3
44% Complete
Complete Filed
CSM027 Hypertension
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM046 Pain Management
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM047 Pain Management
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM048 Pain Management
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM049 Appetite suppressant
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM051 Anticonvulsant
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM052 Pain Management
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM053 CNS
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM054 Antineoplastic
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM055 Antiarrhythmic
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM056 AntiCytomegalovirus
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM057 Anticonvulsants
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM058 Antineoplastic
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM059 Antineoplastic
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM060 Pain Management
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM061 Hypertension
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM062 Progestrone Antagonist
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed
CSM063 CNS
Discovery Preclinical Phase 1 Phase 2 Phase 3
21% Complete
Provisional Filed


* Disclaimer: Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a patent infringement.